<?xml version="1.0" ?>
<document id="d00f2e117b4d930186ab62bb1a94f929435f9aaf">
  <chunk id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c0" text="Interaction of severe acute respiratory syndrome- coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2">
    <entity charOffset="89-97" id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c0.e0" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="103-114" id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c0.e1" ontology_id="CHEBI_2719" text="angiotensin" type="chemical"/>
  </chunk>
  <chunk id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c1" text="Although in different groups, the coronaviruses severe acute respiratory syndrome-coronavirus (SARS-CoV) and NL63 use the same receptor, angiotensin converting enzyme (ACE)-2, for entry into the host cell. Despite this common receptor, the consequence of entry is very different; severe respiratory distress in the case of SARS-CoV but frequently only a mild respiratory infection for NL63. Using a wholly recombinant system, we have investigated the ability of each virus receptor-binding protein, spike or S protein, to bind to ACE-2 in solution and on the cell surface. In both assays, we find that the NL63 S protein has a weaker interaction with ACE-2 than the SARS-CoV S protein, particularly in solution binding, but the residues required for contact are similar. We also confirm that the ACE-2-binding site of NL63 S lies between residues 190 and 739. A lower-affinity interaction with ACE-2 might partly explain the different pathological consequences of infection by SARS-CoV and NL63.">
    <entity charOffset="137-148" id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c1.e0" ontology_id="CHEBI_2719" text="angiotensin" type="chemical"/>
    <entity charOffset="490-497" id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c1.e1" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="510-517" id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c1.e2" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="539-547" id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c1.e3" ontology_id="CHEBI_75958" text="solution" type="chemical"/>
    <entity charOffset="613-620" id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c1.e4" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="677-684" id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c1.e5" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="702-710" id="d00f2e117b4d930186ab62bb1a94f929435f9aaf.c1.e6" ontology_id="CHEBI_75958" text="solution" type="chemical"/>
  </chunk>
</document>
